Skip to main content

Table 3 Relative mRNA concentrations of PPARα target genes in liver and muscle of lactating control sows and sows administered clofibrate on day 20 of lactation

From: Treatment of lactating sows with clofibrate as a synthetic agonist of PPARα does not influence milk fat content and gains of litters

  Control Clofibrate P -value
Liver
ACOX1 1.00 ± 0.61 1.16 ± 0.65 0.577
CD36 1.00 ± 0.38 0.91 ± 0.39 0.656
CPT1A 1.00 ± 0.75 3.86 ± 1.77 0.003
CYP4A24 1.00 ± 0.47 1.66 ± 0.57 0.034
FABP1 1.00 ± 0.36 1.32 ± 0.42 0.144
LPL 1.00 ± 0.49 1.48 ± 0.48 0.104
SLC27A1 1.00 ± 0.47 0.96 ± 0.14 0.835
Muscle
ACO 1.00 ± 0.36 1.62 ± 0.38 0.002
CD36 1.00 ± 0.16 1.43 ± 0.16 < 0.001
CPT1B 1.00 ± 0.37 1.64 ± 0.53 0.001
CYP4A24 1.00 ± 0.38 1.52 ± 0.31 0.012
FABP3 1.00 ± 0.24 1.27 ± 0.35 0.094
LPL 1.00 ± 0.51 1.68 ± 0.48 0.010
SLC27A1 1.00 ± 0.10 1.12 ± 0.14 0.101
UCP3 1.00 ± 0.32 1.16 ± 0.20 0.296
  1. Values are mean ± SD (n = 10/group); Abbreviations: see Footnote of Table 1.